Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Inecalcitol；TX-522;TX522;TX 522 | C26H40O3 | 163217-09-2 | Details |
| Aladotrilat；Fasidotrilat | C14H17NO5S | 135038-59-4 | Details |
| Quifenadine；Fenatin;Fencarol;Phencarol | C20H23NO | 10447-39-9 | Details |
| Isophthalic acid；Acide isophtalique | C8H6O4 | 121-91-5 | Details |
| TMC353121 | C32H42N6O3 | 857066-90-1 | Details |
| AT-9283 HCl；AT 9283;AT9283;AT-9283;AT-9283 hydrochloride | C19H24ClN7O2 | 896466-61-8 | Details |
| DA-11004；DA11004;DA 11004;UNII-48M66E9ER2 | C11H9NO2 | 57404-51-0 | Details |
| Plazomicin | C25H48N6O10 | 1154757-24-0 | Details |
| Benzyldimethylstearylammonium chloride；Benzyldimethylstearylammonium Chloride Hydrate | C27H50ClN | 122-19-0 | Details |
| AMG9090；AMG 9090;AMG-9090 | C15H11Cl4NOS | 118215-82-0 | Details |
| BMS-665053；BMS665053;BMS 665053 | C16H14Cl3F2N3O2 | 1173435-64-7 | Details |
| SMND-309 | C18H14O8 | 1065559-56-9 | Details |
| AH-3960；AH3960;AH 3960 | C13H22N4O3 | 862907-48-0 | Details |
| S-99 | C16H15F3N6O | 1124381-69-6 | Details |
| PHA-408；PHA 408;PHA408 | C29H27ClFN7O2 | 503555-55-3 | Details |
| MP-10 succinate；MP 10;MP10 | C29H26N4O5 | 1037309-45-7 | Details |
| (E/Z)-Zotiraciclib | C23H24N4O | 937270-47-8 | Details |
| Linaclotide acetate；MM416775 MD-1100 acetate;MM 416775;Linzess;MM-416775 | C61H83N15O23S6 | 851199-60-5 | Details |
| YE 120 | C16H9Cl2N3O | 383124-82-1 | Details |
| ONO-1603；ONO1603;ONO 1603 | C16H19ClN2O3 | 117427-00-6 | Details |
| Ulimorelin；TZP-101 | C30H39FN4O4 | 842131-33-3 | Details |
| P505-15 Acetate | C21H27N9O3 | 1370261-98-5 | Details |
| Ro-51 | C17H23IN4O4 | 1050670-85-3 | Details |
| MAL3-101；MAL3101;MAL3 101 | C54H66N4O10 | 831217-40-4 | Details |
| Tranilast Sodium | C18H16NNaO5 | 104931-56-8 | Details |
| COR628；COR-628;COR 628 | C16H23NO3S | 550310-04-8 | Details |
| KL001；KL-001;KL 001 | C21H22N2O4S | 309928-48-1 | Details |
| EMD 281014 hydrochloride | C22H21ClFN4O | 443144-27-2 | Details |
| Nafamostat hydrochloride | C19H18ClN5O2 | 80251-32-7 | Details |
| ASP-6537；ASP 6537;ASP6537;FK 881;FR 122047;FK-881 | C17H17N3O3 | 524699-72-7 | Details |
| Hydroxypropyl-beta-cyclodextrin；HPbCD;HP-beta-CD;HP-beta-CyD;VTS-270;THPB;Hydroxypropyl-beta-cyclodextri | C63H112O42 | 107745-73-3 | Details |
| Methotrexate 1-methyl ester；Methotrexate alpha-methyl ester;Methotrexate related compound I | C21H24N8O5 | 66147-29-3 | Details |
| VU 0360172 hydrochloride | C18H16ClFN2O | 1309976-62-2 | Details |
| Shz 1 | C13H11BrN2O3S | 326886-05-9 | Details |
| JNJ-17029259；JNJ 17029259;JNJ17029259 | C26H30N6O | 314267-57-7 | Details |
| Lansoprazole sodium | C16H13F3N3NaO2S | 226904-00-3 | Details |
| EC-17 free acid；EC-17;FTIC-Folate;Folate-FTIC;EC17;EC 17 | C42H36N10O10S | 583037-91-6 | Details |
| AZD-3463 | C24H25ClN6O | 1356962-20-3 | Details |
| PPI-1019 | C36H54N6O5 | 290828-45-4 | Details |
| Iloperidone hydrochloride | C24H28ClFN2O4 | 1299470-39-5 | Details |
| Canagliflozin hemihydrate；TA 7284;JNJ28431754;JNJ-28431754;TA7284;TA-7284;JNJ 28431754 | 2(C24H25FO5S).H2O | 928672-86-0 | Details |
| PS47 | C17H15ClO2 | 1180676-33-8 | Details |
| AMT hydrochloride | C5H10N2S.ClH | 21463-31-0 | Details |
| KPT185 | C16H16F3N3O3 | 1333151-73-7 | Details |
| NO-711ME | C22H24N2O3 | 127586-66-7 | Details |
| ZK159222 | C32H48O5 | 156965-15-0 | Details |
| GSK2565363C | C48H71ClN2O6 | 1422355-65-4 | Details |
| SCH51048；SCH-51048;SCH 51048 | C37H42F2N8O3 | 161532-65-6 | Details |
| Ro 64-5229 | C17H19Cl2N3O | 246852-46-0 | Details |
| VI 16832 | C22H25N5O2 | 1430218-51-1 | Details |
| JTT-552；JTT 552;JTT552 | C15H12ClNO3 | 888730-46-9 | Details |
| PF-05388169；PF 05388169;PF05388169 | C22H21N3O4 | 1604034-78-7 | Details |
| WAY-213613 | C16H13BrF2N2O4 | 868359-05-1 | Details |
| TPPB | C27H30F3N3O3 | 497259-23-1 | Details |
| IDX184 | C25H35N6O9PS | 1036915-08-8 | Details |
| LY 334370 hydrochloride | C21H23ClFN3O | 199673-74-0 | Details |
| TC-N 1752 | C25H27F3N6O3 | 1211866-85-1 | Details |
| FBPase-1 inhibitor-1 | C13H7Cl3N2O3S | 883973-99-7 | Details |
| AMN082 | C28H29ClN2 | 97075-46-2 | Details |
| DPPI 1c hydrochloride | C14H20N4O2 | 866396-34-1 | Details |
| Azido-PEG2-t-butyl ester | C14H9N3O3 | 20844-48-8 | Details |
| MDL 100009 | C22H28FNO3 | 175673-57-1 | Details |
| Nilotinib monohydrochloride monohydrate；AMN107 (monohydrochloride monohydrate);Nilotinib (monohydrochloride monohydrate) | C28H25ClF3N7O2 | 923288-90-8 | Details |
| Org37684；Org 37684 | C14H19NO2.ClH | 213007-95-5 | Details |
| TG-89 | C26H34N6O3S | 936091-56-4 | Details |
| A-794282 | C19H18N4OS | 869802-44-8 | Details |
| Zaurategrast；CT7758 | C26H25BrN4O3 | 455264-31-0 | Details |
| Glycidyl methacrylate；NSC24156;Glycidol methacrylate;NSC 24156;NSC-24156 | C7H10O3 | 106-91-2 | Details |
| Aza-THIP | C6H9N3O | 654666-65-6 | Details |
| 2'-Hydroxy-4'-methylacetophenone | C9H10O2 | 6921-64-8 | Details |
| DL-AP4 Sodium salt | C4H11NNaO5P | 1263093-79-3 | Details |
| CDPPB | C23H16N4O | 781652-57-1 | Details |
| SKF-82958；Chloro-AP;SKF 82958;(±)-SKF 82958 | C19H20ClNO2 | 80751-65-1 | Details |
| Org27759；Org-27759;Org 27759 | C21H24FN3O | 868273-09-0 | Details |
| PSB-603；PSB 603 | C24H25ClN6O4S | 1092351-10-4 | Details |
| PNU-177864 | C18H21F3N2O3S | 250266-51-4 | Details |
| SJ-172550 | C22H21ClN2O5 | 431979-47-4 | Details |
| Zonisamide sodium | C8H7N2NaO3S | 68291-98-5 | Details |
| TCS 21311 | C27H25F3N4O4 | 1260181-14-3 | Details |
| Nerispirdine HCl；HP 184;Nerispirdine hydrochloride;HP-184;HP184 | C17H19ClFN3 | 119229-64-0 | Details |
| m-PEG11-Tos | C10H14O4S | 58320-73-3 | Details |
| TG101114；TG 101114;TG-101114 | C25H25N5O2S | 937013-83-7 | Details |
| NPEC-caged-dopamine | C17H18N2O6 | 1257326-23-0 | Details |
| Rec 15/2615 dihydrochloride | C26H34ClN5O5 | 173059-17-1 | Details |
| DS2 | C18H12ClN3OS | 374084-31-8 | Details |
| Talsupram hydrochloride | C20H26ClNS | 25487-28-9 | Details |
| TBTC | C14H21NO2S | 213192-26-8 | Details |
| ES 936 | C18H16N2O6 | 192820-78-3 | Details |
| ABT-472；DTXSID70670431;AKOS016845980;A-620223 (HCl salt) | C20H28N4O5 | 943650-25-7 | Details |
| NVP-ADW742；GSK 552602A;ADW742 | C28H31N5O | 475489-15-7 | Details |
| Tubastatin A TFA；Tubastatin A trifluoroacetate salt | C22H22F3N3O4 | 1239262-52-2 | Details |
| LY 2365109 hydrochloride | C22H27NO5 | 868265-28-5 | Details |
| (RS)-MCPG disodium salt | C10H12NNaO4 | 1303994-09-3 | Details |
| Stauprimide | C35H28N4O5 | 154589-96-5 | Details |
| 1-Oleoyl lysophosphatidic acid sodium | C21H40NaO7P | 325465-93-8 | Details |
| BAY 41-8543 | C21H21FN8O | 256498-66-5 | Details |
| (+)-trans-C75 | C14H22O4 | 1234694-20-2 | Details |
| Vicagrel | C18H18ClNO4S | 1314081-53-2 | Details |
| CAY10589；CAY-10589;CAY 10589 | C25H28ClN3O2S | 1077626-52-8 | Details |
| GLPG0259；GLPG-0259;GLPG 0259 | C24H28N8O2 | 959754-85-9 | Details |
| Product Total： Product Page： | ||||
| 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 | ||||